Health and Fitness Health and Fitness
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011

Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011


Published on 2011-10-13 19:00:41 - Market Wire
  Print publication without navigation


Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3,... -- NASHVILLE, Tenn., Oct. 13, 2011 /PRNewswire/ --

Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011

[ ]

NASHVILLE, Tenn., Oct. 13, 2011/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: [ CPIX ]) announced today that it will release third quarter 2011 financial results after the market closes on Thursday, November 3, 2011. A conference call and live Internet webcast will be held on Thursday, November 3, 2011, at 5:00 p.m. Eastern Time to discuss the results.

To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 18137911. The live webcast and rebroadcast can be accessed via Cumberland's website at [ http://investor.shareholder.com/cpix/events.cfm ].

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company's website at [ www.cumberlandpharma.com ].

SOURCE Cumberland Pharmaceuticals Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cumberlandpharma.com ]

Contributing Sources